Our solution is specifically designed for early clinical studies

Accelsiors offers comprehensive services to properly handle constantly moving elements of your first-in-humans and proof-of-concept studies.

Early Phase Clinical Development Solutions (P I – P IIa studies)

Early Phase Clinical Development SolutionsAimed to optimize time and maximize the value of your early phase clinical program, our focused team of experts provides the right scientific integrity, medical insights, regulatory guidance, therapeutic expertise and excellence in project management to move your IMP across development phases more effectively in time and cost.

Our team will help uncover potential risks and opportunities, properly handle constantly moving elements of your study and find the right answers of your burning questions along the way of clinical development.

We offer a complete set of Early Phase Clinical Development Services to properly handle constantly moving elements of your first-in-humans and proof-of-concept studies:

  • Clinical development planning / Protocol design with medical and scientific consultation
  • PK/PD modelling
  • Global regulatory affairs, strategies, facilitation, operation
  • Global early phase investigators network
  • Recruitment and enrollment of healthy volunteers and special patient populations
  • Safety management, Pharmacovigilance
  • Clinical trial project management
  • Data management
  • Bioanalytical services and advanced biostatistics
Feel free to ask Accelsiors’ Early Phase Clinical Development experts!

Let’s start discussing about how we can support your pipeline! Please, contact us:

and we will schedule a meeting around your calendar!

Learn more about our comprehensive clinical development services

Accelsiors offers a complete range of expertise in support of your specific needs: Scientific, analytical and regulatory complemented by global resources, state-of-the-art technologies and project management methodology for the most effective execution of your development program across all phases of clinical drug development.